The Mouse Monoclonal anti-CDK2 antibody has been validated for WB, IHC, ELISA and IP. It is suitable to detect CDK2 in samples from Human, Mouse and Xenopus laevis.
CDK2 antibody can be used in immunohistochemistry starting at 10 μg/mL.
Restrictions
For Research Use only
Format
Liquid
Buffer
0.1M Tris-glycine, pH 7.4, 0.15M sodium chloride, 0.05 % sodium azide, before the addition of glycerol to 30 %
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
As with all antibodies avoid freeze/thaw cycles.
Storage
4 °C/-20 °C
Storage Comment
Store CDK2 antibody at 4 °C or -20 °C.
Target
CDK2
(Cyclin-Dependent Kinase 2 (CDK2))
Alternative Name
CDK2
Background
Cyclin-dependent kinase 2 (CDK2), a CDC2/CDK-type protein kinase, regulates cell-cycle transition from G1 to S phase. CDK2 activation requires formation of a heterodimer with cyclin A, D, or E and phosphorylation by CAK. CDK2 inhibition results from association with p21Cip1 (CDKN1A) and p27Kip1 (CDKN1B). Two alternatively spliced variants and multiple transcription initiation sites have been reported. Inhibition of CDK2 has been suggested to help prevent chemotherapy-induced alopecia in cancer patients.